Rindopepimut
N/A
Report date: 2022/10/14 20:00:43
Base Information
Drug NameRindopepimut
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[24]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins UniversityDuke University Medical Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesCelldex TherapeuticsNational Institutes Of HealthPfizer Inc +[4]
Active IndicationsN/A
Inactive Indications +[5]